title: Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.
abstract: BACKGROUND
  To clarify the efficacy of combined therapy with intravitreal ranibizumab injections and photodynamic therapy (PDT) in patients with symptomatic polypoidal choroidal vasculopathy (PCV).
  
  
  METHODS
  We retrospectively reviewed 57 treatment-naïve eyes of 57 patients. Thirty-two patients were treated with standard fluence PDT (PDT group), and 25 patients were treated with three consecutive monthly intravitreal injections of ranibizumab and standard fluence PDT (ranibizumab plus PDT group). All patients were followed for at least 24 months.
  
  
  RESULTS
  In the ranibizumab plus PDT group, the mean best-corrected visual acuity (BCVA) levels of decimal (logMAR equivalent) significantly improved from 0.30 (0.52) at baseline to 0.55 (0.26) at 24 months (P < 0.001). In the PDT group, the BCVA levels stabilized from 0.26 (0.58) at baseline to 0.25 (0.60) at 24 months. The mean changes in the BCVA in the ranibizumab plus PDT group and the PDT group were improvement of 2.63 lines and decline of 0.16 lines respectively (P = 0.010). The mean number of PDTs at 24 months in the ranibizumab plus PDT group and the PDT group were 1.4 and 2.6 respectively. Increased subretinal hemorrhages were seen in eight (18.0 %) eyes, all of which were belonging to the PDT group.
  
  
  CONCLUSIONS
  Combined intravitreal ranibizumab and PDT was significantly more effective in maintaining and improving VA for PCV patients compared with PDT monotherapy over 24 months.
authors.affiliation: Department of Ophthalmology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan, smasaaki@fmu.ac.jp.
authors.forename: Masaaki
authors.initials: M
authors.lastname: Saito
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Iida
authors.forename: Mariko
authors.initials: M
authors.lastname: Kano
authors.forename: Kanako
authors.initials: K
authors.lastname: Itagaki
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D002829:Choroid / Q000098:blood supply*; D015862:Choroid Diseases / Q000175:diagnosis / Q000188:drug therapy*; D004396:Coloring Agents; D003131:Combined Modality Therapy; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007208:Indocyanine Green; D058449:Intravitreal Injections; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy; D011127:Polyps / Q000175:diagnosis / Q000188:drug therapy*; D000069579:Ranibizumab; D012189:Retrospective Studies; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D004396:Coloring Agents; D007208:Indocyanine Green; D000069579:Ranibizumab
references.citation: N Engl J Med. 2006 Oct 5;355(14):1419-31
references.pmid: 17021318
references.citation: Am J Ophthalmol. 2012 Jul;154(1):117-124.e1
references.pmid: 22465366
references.citation: Nippon Ganka Gakkai Zasshi. 2009 Nov;113(11):1098-103
references.pmid: 19994589
references.citation: Ophthalmology. 2008 Mar;115(3):585-585.e6
references.pmid: 18319105
references.citation: Retina. 2008 May;28(5):717-22
references.pmid: 18463515
references.citation: Am J Ophthalmol. 2007 Jul;144(1):15-22
references.pmid: 17509509
references.citation: Br J Ophthalmol. 2010 Aug;94(8):1045-51
references.pmid: 20530656
references.citation: Am J Ophthalmol. 2011 Apr;151(4):594-603.e1
references.pmid: 21295766
references.citation: Retina. 2011 Sep;31(8):1589-97
references.pmid: 21654347
references.citation: Am J Ophthalmol. 2002 May;133(5):639-48
references.pmid: 11992861
references.citation: Retina. 2012 Jul;32(7):1250-9
references.pmid: 22446886
references.citation: Am J Ophthalmol. 2010 Jul;150(1):48-54.e1
references.pmid: 20609707
references.citation: Retina. 2012 Sep;32(8):1453-64
references.pmid: 22426346
references.citation: Retina. 2012 Jul;32(7):1272-9
references.pmid: 22547209
references.citation: Ophthalmology. 2008 Jan;115(1):141-6
references.pmid: 17582498
references.citation: Retina. 2010 Sep;30(8):1197-205
references.pmid: 20827139
references.citation: Am J Ophthalmol. 2006 Jul;142(1):95-104
references.pmid: 16815256
references.citation: Br J Ophthalmol. 1997 Feb;81(2):154-62
references.pmid: 9059252
references.citation: Retina. 1990;10(1):1-8
references.pmid: 1693009
references.citation: Br J Ophthalmol. 2008 Jan;92(1):70-3
references.pmid: 17567661
references.citation: Br J Ophthalmol. 2010 Jan;94(1):2-13
references.pmid: 19443462
references.citation: Surv Ophthalmol. 2010 Nov-Dec;55(6):501-15
references.pmid: 20850857
references.citation: Am J Ophthalmol. 2009 Jul;148(1):43-58.e1
references.pmid: 19376495
references.citation: Graefes Arch Clin Exp Ophthalmol. 2000 Sep;238(9):752-9
references.pmid: 11045343
references.citation: Retina. 2011 Jul-Aug;31(7):1287-93
references.pmid: 21386762
references.citation: Retina. 1995;15(2):100-10
references.pmid: 7542796
references.citation: Am J Ophthalmol. 2006 Mar;141(3):456-62
references.pmid: 16490490
references.citation: N Engl J Med. 2006 Oct 5;355(14):1432-44
references.pmid: 17021319
references.citation: Br J Ophthalmol. 2008 Dec;92(12):1642-7
references.pmid: 18782798
references.citation: Arch Ophthalmol. 1999 Oct;117(10):1329-45
references.pmid: 10532441
references.citation: Retina. 2011 Mar;31(3):464-74
references.pmid: 20948458
references.citation: Arch Ophthalmol. 1997 Apr;115(4):478-85
references.pmid: 9109756
references.citation: Am J Ophthalmol. 2010 Jun;149(6):947-954.e1
references.pmid: 20346441
references.citation: Am J Ophthalmol. 2008 Oct;146(4):513-519
references.pmid: 18614133
references.citation: Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1929-34
references.pmid: 8759365
references.citation: Br J Ophthalmol. 2010 Mar;94(3):297-301
references.pmid: 19726427
references.citation: Retina. 2011 Sep;31(8):1581-8
references.pmid: 21610566
references.citation: Invest Ophthalmol Vis Sci. 2007 May;48(5):2254-9
references.pmid: 17460288